[{"orgOrder":0,"company":"Shanton Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Rheumatology","country":"U.S.A","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"SAP-001","moa":"Glucose transporter type 9 (GLUT9)","graph1":"Rheumatology","graph2":"Phase II","graph3":"Shanton Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Shanton Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Shanton Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Shanton Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Rheumatology","country":"U.S.A","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"SAP-001","moa":"Glucose transporter type 9 (GLUT9)","graph1":"Rheumatology","graph2":"Phase II","graph3":"Shanton Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Shanton Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Shanton Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Shanton Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Rheumatology","country":"U.S.A","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"SAP-001","moa":"Glucose transporter type 9 (GLUT9)","graph1":"Rheumatology","graph2":"Phase II","graph3":"Shanton Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Shanton Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Shanton Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Shanton Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Rheumatology","country":"U.S.A","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"SAP-001","moa":"Glucose transporter type 9 (GLUT9)","graph1":"Rheumatology","graph2":"Phase II","graph3":"Shanton Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shanton Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Shanton Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Shanton Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Rheumatology","country":"U.S.A","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"SAP-001","moa":"Glucose transporter type 9 (GLUT9)","graph1":"Rheumatology","graph2":"Phase II","graph3":"Shanton Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shanton Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Shanton Pharma \/ Undisclosed"}]